Colorectal cancer is a common malignancy which carries the same threat to survival now as it did 30 years ago. There is some evidence that adjuvant chemo-or radiotherapy may improve local recurrence rates and survival (Laurie et al., 1989; Jones et al., 1989; Metzger, 1991) . The ability to accurately detect patients who may need and respond favourably to additional treatment would be an advantage and would increase the likelihood of determining potential benefits of adjuvant therapy. The measurement of tumour proliferation may help in the identification of tumours which, because of their rapidly proliferative nature, might benefit from modification of their radiotherapy (Dische & Saunder, 1989) ; and secondly may be more susceptible to chemotherapy than less proliferative lesions (Riccardi et al., 1991) .
The measurement of tumour potential doubling time (Tp,,) using in vivo bromodeoxyuridine (BUdR) or iododeoxyuridine (IUdR) and dual parameter flow cytometry can be performed on pre-operative biopsies (Begg et al., 1985) . Previous studies have indicated that this technique will yield results on pieces of tissue of less than 100 mg (Wilson & McNally, 1991) . No relationship has been shown between proliferation measured in this way and tumour stage or grade Rew et al., 1991 Rew et al., , 1992 , whilst values for Tpot have been reported to be independent of age, sex and tumour site or size (Wilson, 1991) . These findings suggest that Tp,t may be independent of prognostic value. The validity of this measurement, however, would depend to a degree on the extent of heterogeneity present within a tumour, the amount of which would dictate the number of biopsies required to obtain a reliable impression of the most proliferative or dominant cellular sub-population of the tumour.
It is well established that colorectal cancer is a heterogeneous tumour. For example, this has previously been demonstrated with respect to tumour DNA content (Scott et al., 1987; Koha et al., 1990; Wersto et al., 1991; Hiddemann et al., 1986) , S phase fraction (Lindmark et al., 1991; Kouri et al., 1990) , and expression of Ki67, a marker of proliferation (Shepherd et al., 1988) . In this study the degree of intra-tumoral heterogeneity present in tumour DNA content, expressed as the DNA index (DI) and IUdR related flow cytometric parameters (labelling index, LI; DNA synthesis time, T7; and Tp,,) have been assessed.
Materials and methods

Samples
Thirty patients with proven colorectal adenocarcinomas were given 200 mg of IUdR (Boehringher Mannheim) as an intravenous bolus with hospital Ethical Committee approval and full informed consent. After 4-14.7 h (mean 8.1 ± 2.9 h) random biopsies were taken from the resected surgical specimen and the time (t) was recorded between the administration of the IUdR and the removal of the surgical specimen from the individual patients. All of the patients were treated by surgery with none receiving prior chemo-or radiotherapy. Twenty-seven tumours had six biopsies taken, two tumours had five biopsies and one tumour had two biopsies taken. Randomisation of multiple specimens was achieved by sampling from completely separate parts of obvious tumour in a clockwise direction. All samples were of analysable quality except for three samples from two tumours, both of which were from the 27 tumours biopsied six times. The biopsy specimens were immediately placed into 70% ethanol at 4°C in the operating theatre. Parallel samples were fixed in formalin for histopathological assessment. In 26 tumours, a pooled 'homogenate' sample was prepared from each of the multiple samples. This consisted of equal portions from all six biopsies taken from each patient. Each sample was thoroughly minced and mixed before preparation for flow cytometry.
IUdRIDNA staining procedure The method of sample preparation and analysis has been described in detail elsewhere (Wilson & McNally, 1991; Wilson et al., 1988) . In summary, on the day of analysis the specimens were minced, then digested using 0.4 mg ml-' pepsin in 0.1 M HCI and the DNA partially denatured using 2 M HCI for 15 min to expose the IUdR-incorporated DNA. Approximately 2 x 106 nuclei were incubated with a 1 in 20 dilution of anti-IUdR monoclonal antibody (BectonDickinson) for I h hour at room temperature. After washing, 30 min. Finally, the nuclei were counterstained with propidium iodide (Sigma) at a concentration of 10ligml-' to allow measurement of the total DNA content.
Data analysis
All the samples were analysed using an Ortho Systems 50H Cytofluorograph (Becton-Dickinson) with 1024 channels. The data analysis was performed in list mode by a single observer. Measurements were made of tumour ploidy (DI), labelling index (LI) and relative movement (RM), allowing calculation of tumour DNA synthesis time (Ts) and the potential doubling time of the tumour (Tpo,) as previously described (Begg et al., 1985) . Tpo, was calculated from: T Tpo = 0.8 xLI (1) where 0.8 was the value assigned to A, a factor which accounted for the variation in the age structure of the cells (Steel, 1977) . Ts was derived by:
where t was the time period in hours between injection of IUdR and tumour biopsy and RM was the 'relative movement' of the labelled nuclei through the cell cycle. This was calculated by subtracting the mean DNA content of the G, population from that obtained for the IUDR labelled nuclei and dividing it by the mean DNA content of the G, subtracted from the mean of the G2 x M cells as follows Statistical analysis Spearman's rank correlation coefficients (r) and paired t-tests were used to compare sets of parameters measured on the same samples of tumours. One way analysis of variance was used to determine the overall coefficients of variation (CV). Mean CVs are provided for comparative purposes. These were computed as a single average of the CV values for individual tumours and as such take no account of the different numbers of samples assessed. Ln(Tp7,) and In (Ts) were used in preference to the untransformed values as this gave a more normal distribution. A significance level of 0.05 was used throughout. Table I lists the classification of the 30 tumours with regards to tumour position, stage and histological differentiation.
Results
Clinical details
Tumour DNA content (DI) Fourteen (47%) of the tumours were diploid and 16 tumours had aneuploid populations. Twelve of the latter were wholly aneuploid but in four there was a mixed population of both diploid and aneuploid cells. In these four tumours, two tumours had four of six biopsies which were diploid, one had three diploid biopsies out of six and one had two diploid biopsies out of six. Three of the four tumours had homogenate samples prepared; one of which was diploid. In this latter tumour, four out of the six biopsies were diploid. In the 12 tumours that were wholly aneuploid, the coefficient of variation (CV) of the DI ranged from two to 21%, the overall CV was 6%.
IUdR related parameters Homogenate Tpot (days) Figure 3 The relationship between the homogenate Tpo, value and a, the median value and b, the shortest value. (Zamcheck et al., 1975; Leibowitz et al., 1976) Siracky, 1979) , in vitro growth characteristics (Dexter et al., 1981; Kimball & Brattain, 1980) and in the kinetics of the tumours as demonstrated by the measurement of S phase fraction (Lindmark et al., 1991; Kouri et al., 1990) and Ki67 labelling (Shepherd et al., 1988) and the presence of multiple DNA stemlines measured by flow cytometry (Hiddemann et al., 1986 (Begg et al., 1988; Bennett et al., 1992) and breast carcinomas (Rew et al., 1992) . Although there is a significant degree of intra-tumoral heterogeneity (ln(TpO,) CV 22%), it compares favourably with the amount of inter-tumoral variation present (ln(Tp,01) CV 63%), indicating the ability to identify individual tumour proliferation characteristics (Table   II) .
Other studies have suggested that LI is the most variable factor involved in the production of Tpo, (Table III) (Begg et al., 1990) . Whilst this does seem to provide some degree of discrimination of tumours that will fare better with hyperfractionated radiotherapy, the present study indicates that if only a single biopsy is performed in colorectal tumours, it would be possible to place individuals into the wrong group (Figure 1) . Twenty of the 30 tumours had samples whose Tp0, values were both above and below the overall median value. An homogenate sample might give an accurate overall impression of the tumour's proliferative nature. This would allow analysis of a single pooled sample from a tumour which had been sampled in a multiple manner. It has been suggested that either measuring several small pieces independently or obtaining and processing as large a piece as possible at one time by cutting it into small pieces before adding the pepsin should provide similar mean parameter values (Begg et al., 1988) . In this study, there were significant differences between the homogenate and the median or shortest Tp0, values (P = 0.04 and <0.001 respectively), but there were good correlations between the homogenate and either the median (r = 0.69) or the shortest (r = 0.75) Tp,,, values and one tumour had a value which was longer than any of the individual values. This probably reflects heterogeneity within the individual biopsies. Two separate parts of each biopsy were taken. One was used to obtain the biopsy Tp,, value and the other was pooled with other multiple samples, disaggregated and then processed to give the homogenate data.
In conclusion, because of the degree of intra-tumoral heterogeneity, this study would support the need for multiple sampling in order to correctly measure not only ploidy but also the proliferation of colorectal tumours. Secondly, the data suggest that the analysis of an homogenate may allow a more rapid analysis of a multiply sampled tumour. Finally, whilst there is significant intra-tumoral variation, it is less than inter-tumoral variation and therefore the former should not be a limitation to the possible usefulness of this technique as an independent prognostic indicator.
